122 related articles for article (PubMed ID: 20575024)
1. Analysis of the REL, BCL11A, and MYCN proto-oncogenes belonging to the 2p amplicon in chronic lymphocytic leukemia.
Deambrogi C; De Paoli L; Fangazio M; Cresta S; Rasi S; Spina V; Gattei V; Gaidano G; Rossi D
Am J Hematol; 2010 Jul; 85(7):541-4. PubMed ID: 20575024
[No Abstract] [Full Text] [Related]
2. Array comparative genomic hybridization analysis identifies recurrent gain of chromosome 2p25.3 involving the ACP1 and MYCN genes in chronic lymphocytic leukemia.
Ma D; Chen Z; Patel KP; Mishra BM; Yao H; Abruzzo LV; Medeiros LJ; Wierda W; Keating M; Sargent R; Luthra R
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1(Suppl 1):S17-24. PubMed ID: 22035742
[TBL] [Abstract][Full Text] [Related]
3. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.
Martín-Subero JI; Gesk S; Harder L; Sonoki T; Tucker PW; Schlegelberger B; Grote W; Novo FJ; Calasanz MJ; Hansmann ML; Dyer MJ; Siebert R
Blood; 2002 Feb; 99(4):1474-7. PubMed ID: 11830502
[TBL] [Abstract][Full Text] [Related]
4. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies.
Satterwhite E; Sonoki T; Willis TG; Harder L; Nowak R; Arriola EL; Liu H; Price HP; Gesk S; Steinemann D; Schlegelberger B; Oscier DG; Siebert R; Tucker PW; Dyer MJ
Blood; 2001 Dec; 98(12):3413-20. PubMed ID: 11719382
[TBL] [Abstract][Full Text] [Related]
5. Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages.
Chapiro E; Leporrier N; Radford-Weiss I; Bastard C; Mossafa H; Leroux D; Tigaud I; De Braekeleer M; Terré C; Brizard F; Callet-Bauchu E; Struski S; Veronese L; Fert-Ferrer S; Taviaux S; Lesty C; Davi F; Merle-Béral H; Bernard OA; Sutton L; Raynaud SD; Nguyen-Khac F
Leuk Res; 2010 Jan; 34(1):63-8. PubMed ID: 19406473
[TBL] [Abstract][Full Text] [Related]
6. MYCN gene overrepresentation detected in primary neuroblastoma tumour cells without amplification.
Valent A; Le Roux G; Barrois M; Terrier-Lacombe MJ; Valteau-Couanet D; Léon B; Spengler B; Lenoir G; Bénard J; Bernheim A
J Pathol; 2002 Dec; 198(4):495-501. PubMed ID: 12434419
[TBL] [Abstract][Full Text] [Related]
7. Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma.
Weber A; Imisch P; Bergmann E; Christiansen H
J Clin Oncol; 2004 Jul; 22(13):2681-90. PubMed ID: 15226335
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of p53 and amplification of MYCN gene in a terminal lymphoblastic relapse in a chronic lymphocytic leukemia patient.
Stano-Kozubik K; Malcikova J; Tichy B; Kotaskova J; Borsky M; Hrabcakova V; Francova H; Valaskova I; Bourkova L; Smardova J; Doubek M; Brychtova Y; Pospisilova S; Mayer J; Trbusek M
Cancer Genet Cytogenet; 2009 Feb; 189(1):53-8. PubMed ID: 19167613
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of B-cell chronic lymphocytic leukemia: analysis of 13q14 chromosomal deletions.
Migliazza A; Cayanis E; Bosch-Albareda F; Komatsu H; Martinotti S; Toniato E; Kalachikov S; Bonaldo MF; Jelene P; Ye X; Rzhetsky A; Qu X; Chien M; Inghirami G; Gaidano G; Vitolo U; Saglio G; Resegotti L; Zhang P; Soares MB; Russo J; Fischer SG; Edelman IS; Efstratiadis A; Dalla-Favera R
Curr Top Microbiol Immunol; 2000; 252():275-84. PubMed ID: 11125485
[No Abstract] [Full Text] [Related]
10. Amplified MYCN in human neuroblastoma: paradigm for the translation of molecular genetics to clinical oncology.
Schwab M
Ann N Y Acad Sci; 2002 Jun; 963():63-73. PubMed ID: 12095930
[TBL] [Abstract][Full Text] [Related]
11. Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations.
Schwaenen C; Nessling M; Wessendorf S; Salvi T; Wrobel G; Radlwimmer B; Kestler HA; Haslinger C; Stilgenbauer S; Döhner H; Bentz M; Lichter P
Proc Natl Acad Sci U S A; 2004 Jan; 101(4):1039-44. PubMed ID: 14730057
[TBL] [Abstract][Full Text] [Related]
12. Genes proximal and distal to MYCN are highly expressed in human neuroblastoma as visualized by comparative expressed sequence hybridization.
Stock C; Bozsaky E; Watzinger F; Poetschger U; Orel L; Lion T; Kowalska A; Ambros PF
Am J Pathol; 2008 Jan; 172(1):203-14. PubMed ID: 18165268
[TBL] [Abstract][Full Text] [Related]
13. [Methods of detection and prognostic significance of genetic material increase of the short arm of chromosome 2 and a deletion of the short arm of chromosome 1 in patients with neuroblastoma].
Druĭ AE; Tsaur GA; Shorikov EV; Popov AM; Plekhanova OM; Typonogov SN; Savel'ev LI; Tsvirenko SV; Fechina LG
Vopr Onkol; 2013; 59(5):591-8. PubMed ID: 24260886
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion.
Yasukawa K; Liew LC; Hagiwara K; Hironaka-Mitsuhashi A; Qin XY; Furutani Y; Tanaka Y; Nakagama H; Kojima S; Kato T; Ochiya T; Gailhouste L
Cancer Sci; 2020 Mar; 111(3):869-880. PubMed ID: 31883160
[TBL] [Abstract][Full Text] [Related]
15. 2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics.
Jeison M; Ash S; Halevy-Berko G; Mardoukh J; Luria D; Avigad S; Feinberg-Gorenshtein G; Goshen Y; Hertzel G; Kapelushnik J; Ben Barak A; Attias D; Steinberg R; Stein J; Stark B; Yaniv I
Am J Pathol; 2010 Jun; 176(6):2616-25. PubMed ID: 20395439
[TBL] [Abstract][Full Text] [Related]
16. Neuroblastoma in a pediatric patient with a microduplication of 2p involving the MYCN locus.
Van Mater D; Knelson EH; Kaiser-Rogers KA; Armstrong MB
Am J Med Genet A; 2013 Mar; 161A(3):605-10. PubMed ID: 23401364
[TBL] [Abstract][Full Text] [Related]
17. TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma.
Selmi A; de Saint-Jean M; Jallas AC; Garin E; Hogarty MD; Bénard J; Puisieux A; Marabelle A; Valsesia-Wittmann S
Cancer Lett; 2015 Feb; 357(1):412-418. PubMed ID: 25475555
[TBL] [Abstract][Full Text] [Related]
18. Patterns of nuclear proto-oncogene expression during induced differentiation and proliferation of human B chronic lymphocytic leukaemia cells.
Murphy JJ; Tracz M; Norton JD
Immunology; 1990 Mar; 69(3):490-3. PubMed ID: 2312171
[TBL] [Abstract][Full Text] [Related]
19. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression.
Liu PY; Erriquez D; Marshall GM; Tee AE; Polly P; Wong M; Liu B; Bell JL; Zhang XD; Milazzo G; Cheung BB; Fox A; Swarbrick A; Hüttelmaier S; Kavallaris M; Perini G; Mattick JS; Dinger ME; Liu T
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24906397
[TBL] [Abstract][Full Text] [Related]
20. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value.
Vandesompele J; Edsjö A; De Preter K; Axelson H; Speleman F; Påhlman S
Oncogene; 2003 Jan; 22(3):456-60. PubMed ID: 12545167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
